Hiding in the yolk: A unique feature of Legionella pneumophila infection of zebrafish

PLoS Pathog. 2023 May 8;19(5):e1011375. doi: 10.1371/journal.ppat.1011375. eCollection 2023 May.

Abstract

The zebrafish has become a powerful model organism to study host-pathogen interactions. Here, we developed a zebrafish model to dissect the innate immune response to Legionella pneumophila during infection. We show that L. pneumophila cause zebrafish larvae death in a dose dependent manner. Additionally, we show that macrophages are the first line of defence and cooperate with neutrophils to clear the infection. Immunocompromised humans have an increased propensity to develop pneumonia, similarly, when either macrophages or neutrophils are depleted, these "immunocompromised" larvae become lethally sensitive to L. pneumophila. Also, as observed in human infections, the adaptor signalling molecule Myd88 is not required to control disease in the larvae. Furthermore, proinflammatory cytokine genes il1β and tnf-α were upregulated during infection, recapitulating key immune responses seen in human infection. Strikingly, we uncovered a previously undescribed infection phenotype in zebrafish larvae, whereby bloodborne, wild type L. pneumophila invade and grow in the larval yolk region, a phenotype not observed with a type IV secretion system deficient mutant that cannot translocate effectors into its host cell. Thus, zebrafish larva represents an innovative L. pneumophila infection model that mimics important aspects of the human immune response to L. pneumophila infection and will allow the elucidation of mechanisms by which type IV secretion effectors allow L. pneumophila to cross host cell membranes and obtain nutrients from nutrient rich environments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Immunity, Innate
  • Larva
  • Legionella pneumophila*
  • Legionnaires' Disease*
  • Macrophages
  • Zebrafish

Grants and funding

Work in the CB laboratory is financed by the Fondation pour la Recherche Médicale (FRM) grant EQU201903007847 and the grant ANR-10-LABX-62-IBEID and ANR-22-CE15 0009 01 ZebraLegion. Work in ECG group is financed by ANR 17-CE15-0026 and 20-CE15-0024 and ANR-22-CE15 0009 01 ZebraLegion. Valerio Laghi is funded by ANR 20-CE15-0024. The funders, other than the authors, did not play any role in the study or in the preparation of the article or decision to publish.